Roth Capital Cuts PT on Heat Biologics (HTBX) by ~27% Following HS-410 Phase 2 Data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
Go back to Roth Capital Cuts PT on Heat Biologics (HTBX) by ~27% Following HS-410 Phase 2 Data
December 1, 2016 6:09 AM EST
Prospectus Supplement No. 14
Filed Pursuant to Rule... More
December 1, 2016 6:07 AM EST
UNITED... More